By 1 April 1973, 770 patients with malignancy were studied using Gallium‐67 (67Ga) citrate radioisotopic scanning at the Clinical Center, National Institutes of Health. Of these, 21 had brain tumors, 19 (90%) of which concentrated 67Ga. Forty‐four patients with melanoma had 54% of proven sites visualized on 67Ga scan (masses larger than 2 cm were detected in 75% of the sites). Ewing's sarcoma was studied in 15 patients with 67Ga scanning and all 15 primary tumors were visualized. Thirty‐two of 43 scans performed on 30 patients with acute leukemia were abnormal. Sites of leukemic involvement in bone marrow and as myeloblastomas in soft tissue contained high levels of 67Ga. Patients with untreated Hodgkin's disease were abnormal in 90% of cases on 67Ga scan with 70% of proven sites of involvement being detectable. Sixty percent of non‐Hodgkin's lymphoma sites were detected on 67Ga scans. Approximately 85% of anatomic sites involved with lung cancer were detected on scan. 67Ga citrate whole body scanning has proven to be useful in diagnosing and staging a wide variety of human tumors. The 67Ga study is most reliable when positive findings are recorded, but should be approached with caution when the findings are negative.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.